These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 26446)

  • 1. Biochemical evidence for the dual action of labetalol on alpha- and beta-adrenoceptors.
    Aggerbeck M; Guellaen G; Hanoune J
    Br J Pharmacol; 1978 Apr; 62(4):543-8. PubMed ID: 26446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interaction of labetalol with alpha- and beta-adrenergic receptors : biochemical study (author's transl)].
    Dausse JP; Guicheney P; Maich PJ; Meyer P
    Nouv Presse Med; 1978 Oct; 7(35):3121-3. PubMed ID: 31601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The alpha- and beta-adrenoceptor blocking activities of labetalol and its RR-SR (50:50) stereoisomers.
    Riva E; Mennini T; Latini R
    Br J Pharmacol; 1991 Dec; 104(4):823-8. PubMed ID: 1687367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Labetalol binding to specific alpha- and beta-adrenergic sites in vitro and its antagonism of adrenergic responses in vivo.
    Greenslade FC; Tobia AJ; Madison SM; Krider KM; Newquist KL
    J Mol Cell Cardiol; 1979 Aug; 11(8):803-11. PubMed ID: 226721
    [No Abstract]   [Full Text] [Related]  

  • 5. Change of coupling system of receptor-adenylate cyclase induced by epinephrine and GTP in plasma membranes of rat liver.
    Okamura N; Terayama H
    Biochim Biophys Acta; 1978 Nov; 544(1):113-27. PubMed ID: 214146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypotensive effect of labetalol on intraocular pressure in rabbits: in relation to its alpha- and beta-adrenergic blocking action on the cardiovascular system.
    Kogure H; Hosaka A; Abiko Y
    Arch Int Pharmacodyn Ther; 1981 Mar; 250(1):109-22. PubMed ID: 6268004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay.
    Asano M; Hashimoto H; Nakashima M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):34-46. PubMed ID: 6135396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT; Levy GP
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of alpha-adrenoceptors in the rabbit heart by [3H]-dihydroergocryptine binding.
    Schümann HJ; Brodde OE
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Sep; 308(3):191-8. PubMed ID: 41191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of adrenergic receptors and catecholamine-stimulated adenylate cyclase in hog pial membranes.
    Friedman AH; Davis JN
    Brain Res; 1980 Feb; 183(1):89-102. PubMed ID: 6244051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Exogenous adrenergic stimulation by intravenous infusions of isoproterenol and blood levels of cyclic AMP before and after beta-blocking in humans].
    Nami R; Pizzuti M; Nardi PL; D'Ascenzo G; Maioli E; Gennari C
    Boll Soc Ital Cardiol; 1980; 25(7):763-8. PubMed ID: 6115658
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro determination of the ability of drugs to bind to adrenergic receptors.
    Neufeld AH; Page ED
    Invest Ophthalmol Vis Sci; 1977 Dec; 16(12):1118-24. PubMed ID: 200584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic alpha-adrenergic receptors. Identification and subcellular localization using [3H]dihydroergocryptine.
    Clarke WR; Jones LR; Lefkowitz RJ
    J Biol Chem; 1978 Sep; 253(17):5975-9. PubMed ID: 210164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of myocardial beta-adrenoceptors by the nitrogen-free low affinity ligand 3',4'-dihydroxy-alpha-methylpropiophenone (U-0521).
    Kaumann AJ; Wittmann R; Birnbaumer L; Hoppe BH
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Feb; 296(3):217-28. PubMed ID: 14306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Aralkyl substitution increases the affinity of adrenergic drugs for the alpha-adrenoceptor in rat liver.
    Aggerbeck M; Guellaën G; Hanoune J
    Br J Pharmacol; 1979 Jan; 65(1):155-9. PubMed ID: 216448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-adrenergic receptors in rat myocardium. Identification by binding of [3H]dihydroergocryptine.
    Williams RS; Lefkowitz RJ
    Circ Res; 1978 Nov; 43(5):721-7. PubMed ID: 213201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of adrenergic stimulation of hepatic adenylate cyclase by divalent cations.
    Jackowski MM; Johnson RA; Exton JH
    Biochim Biophys Acta; 1982 Jan; 714(1):74-83. PubMed ID: 6275906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pharmacology of adenylate cyclase-coupled alpha- and beta-adrenergic receptors.
    Lefkowitz RJ; De Lean A; Hoffman BB; Stadel JM; Kent R; Michel T; Limbird L
    Adv Cyclic Nucleotide Res; 1981; 14():145-61. PubMed ID: 6269377
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-adrenergic receptor in the brain: comparison of 3H-dihydroalprenolol binding sites and a beta-adrenergic receptor regulating adenylyl cyclase activity in cell free homogenates.
    Cote TE; Kebabian JW
    Life Sci; 1978 Oct; 23(16):1703-13. PubMed ID: 31528
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of beta-adrenergic receptors using [3H]dihydroalprenolol in fetal sheep heart: direct evidence of qualitative similarity to the receptors in adult sheep heart.
    Cheng JB; Goldfien A; Cornett LE; Roberts JM
    Pediatr Res; 1981 Aug; 15(8):1083-7. PubMed ID: 6115356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.